| | | | | | | | | | |
|
|
| Dockets Entered
On September 21, 2004
Table of Contents
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1976N-0366
|
| Prov Listed Color Additives; Postponment of Closing Dates
|
|
|
| 2000N-1571
|
| Enrofloxacin for Poultry: Opportunity for Hearing
|
|
|
| 2003P-0274
|
| In re Tier 1 initial Approval Program
|
|
|
| 2004D-0283
|
| Waivers of In Vivo Demonstration of Bioequivalence of Animal Drugs in Soluble Powder Oral Dosage Form Products and Type A Medicated Articles
|
|
|
| 2004D-0343
|
| Hospital Bed System Dimensional Guidance to Reduce Entrapment
|
|
|
| 2004F-0374
|
| Amend food additive regulations in 172.380 Vitamin D3 to permit the use of vitamin D3 in cheese and cheese products at a level above that permitted under 184.1950 Vitamin D
|
|
|
| 2004N-0257
|
| Recordkeeping Requirements for Human Food and Cosmetics Manufactured from Processed With, or Otherwise Containing Meterial form Cattle
|
|
|
| 2004N-0264
|
| Federal Measures to Mitigate BSE Risks: Considerations for Further Action
|
|
|
| 2004N-0330
|
| Suicidality in Clinical Trials for Antidepressant Drugs in Pediatric Patients
|
|
|
| 2004N-0355
|
| Scientific Considerations Related to Developing Follow-on Protein Products
|
|
|
| 2004P-0276
|
| Initiate proceedings to permit Computerized Thermal Imaging, Inc. (CTI) to supplement the administrative record in connection with CTI's premarket approval application in P010035
|
|
|
| 1976N-0366
|
| Prov Listed Color Additives; Postponment of Closing Dates
|
|
|
| ANS 24
|
| Regulatory Affairs
|
| Vol #:
|
| 433
|
|
|
| 2000N-1571
|
| Enrofloxacin for Poultry: Opportunity for Hearing
|
|
|
| EXB 506
|
| Center for Veterinary Medicine
|
| Vol #:
|
| 432
|
|
|
| EXB 507
|
| Center for Veterinary Medicine
|
| Vol #:
|
| 432
|
|
|
| EXB 508
|
| Center for Veterinary Medicine
|
| Vol #:
|
| 432
|
|
|
| EXB 509
|
| Center for Veterinary Medicine
|
| Vol #:
|
| 432
|
|
|
| EXB 510
|
| Center for Veterinary Medicine
|
| Vol #:
|
| 432
|
|
|
| EXB 511
|
| Center for Veterinary Medicine
|
| Vol #:
|
| 432
|
|
|
| EXB 512
|
| Center for Veterinary Medicine
|
| Vol #:
|
| 432
|
|
|
| EXB 513
|
| Center for Veterinary Medicine
|
| Vol #:
|
| 432
|
|
|
| EXB 514
|
| Center for Veterinary Medicine
|
| Vol #:
|
| 432
|
|
|
| 2003P-0274
|
| In re Tier 1 initial Approval Program
|
|
|
| SUP
1
|
| Abigail Alliance
|
| Vol #:
|
| 4
|
|
|
| 2004D-0283
|
| Waivers of In Vivo Demonstration of Bioequivalence of Animal Drugs in Soluble Powder Oral Dosage Form Products and Type A Medicated Articles
|
|
|
| EXT
1
|
| Animal Health Institute (AHI)
|
| Vol #:
|
| 1
|
|
|
| 2004D-0343
|
| Hospital Bed System Dimensional Guidance to Reduce Entrapment
|
|
|
| C 1
|
| D. Beardsley
|
| Vol #:
|
| 1
|
|
|
| 2004F-0374
|
| Amend food additive regulations in 172.380 Vitamin D3 to permit the use of vitamin D3 in cheese and cheese products at a level above that permitted under 184.1950 Vitamin D
|
|
|
| C
1
|
| Purdue University
|
| Vol #:
|
| 1
|
|
|
| C
2
|
| Creighton University
|
| Vol #:
|
| 1
|
|
| | | | | | | | |
|
|
| 2004N-0257
|
| Recordkeeping Requirements for Human Food and Cosmetics Manufactured from Processed With, or Otherwise Containing Meterial form Cattle
|
|
|
| C
15
|
| Food Safety and Inpection Service (FSIS)
|
| Vol #:
|
| 3
|
|
|
| 2004N-0264
|
| Federal Measures to Mitigate BSE Risks: Considerations for Further Action
|
|
|
| C
136
|
| National Cattlemen's Beef Assn (NCBA)
|
| Vol #:
|
| 22
|
|
|
| C
137
|
| Public Citizen
|
| Vol #:
|
| 22
|
|
|
| C
138
|
| Center for Science in the Public Interest (CSPI)
|
| Vol #:
|
| 22
|
|
|
| C
139
|
| Humane Society of the United States (HSUS)
|
| Vol #:
|
| 22
|
|
|
| C
140
|
| McDonald's Corporation
|
| Vol #:
|
| 22
|
|
|
| C
141
|
| North American Natural Casing Assn (NANCA)
|
| Vol #:
|
| 22
|
|
|
| C
142
|
| National Renderers Assn
|
| Vol #:
|
| 22
|
|
|
| C
143
|
| G.A.O.B., Inc.
|
| Vol #:
|
| 22
|
|
|
| C
144
|
| Gelatin Manufacturers of Europe (GME)
|
| Vol #:
|
| 22
|
|
|
| C
145
|
| IBM Business Consulting Services
|
| Vol #:
|
| 22
|
|
|
| C 146
|
| L. Fischer
|
| Vol #:
|
| 22
|
|
|
| C 147
|
| C. Rothenfluch
|
| Vol #:
|
| 22
|
|
|
| C 148
|
| C. Addonizio
|
| Vol #:
|
| 22
|
|
|
| C 149
|
| M. Clifton
|
| Vol #:
|
| 22
|
|
|
| 2004N-0330
|
| Suicidality in Clinical Trials for Antidepressant Drugs in Pediatric Patients
|
|
|
| C
4
|
| Hardy Healthcare Associates, P.C.
|
| Vol #:
|
| 1
|
|
|
| 2004N-0355
|
| Scientific Considerations Related to Developing Follow-on Protein Products
|
|
|
| C
1
|
| Biogen Idec
|
| Vol #:
|
| 1
|
|
|
| 2004P-0276
|
| Initiate proceedings to permit Computerized Thermal Imaging, Inc. (CTI) to supplement the administrative record in connection with CTI's premarket approval application in P010035
|
|
|
|
|
|
| LET
1
|
| HF-22 to Sidley Austin Brown and Wood L.L.P.
|
| Vol #:
|
| 2
|
|